Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company HealthLinx Ltd.
DescriptionFirst-generation ovarian cancer diagnostic that measures 5 biomarkers
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose ovarian cancer
Regulatory Designation
PartnerCytogenDx Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today